Cargando…

Eruptive keloids associated with aromatase inhibitor therapy

Detalles Bibliográficos
Autores principales:	Meade, Cathy, Smith, Samantha, Makhzoumi, Zaineb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808699/ https://www.ncbi.nlm.nih.gov/pubmed/27051701 http://dx.doi.org/10.1016/j.jdcr.2015.01.008

Ejemplares similares

Acute graft-versus-host disease arising within tattooed skin
por: Meade, Cathy, et al.
Publicado: (2015)

Eruptive keloids after chickenpox
por: Kluger, Nicolas, et al.
Publicado: (2011)

Segmental Erythema Multiforme-Like Drug Eruption by Aromatase Inhibitor Anastrozole – First Case Report and another Example of an Immunocompromised District
por: Wollina, Uwe, et al.
Publicado: (2018)

Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor
por: Schwartz, Melissa, et al.
Publicado: (2015)

Cutaneous sarcoidosis possibly associated with aromatase inhibitors and tamoxifen
por: Sawada, Tomoya, et al.
Publicado: (2023)

Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
por: Najjar, Omar, et al.
Publicado: (2020)

Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007)

Does Aromatase Inhibitors Cause Sjogren’s Syndrome and Polyneuropathy?
por: Yasar Bilge, Nazife Sule, et al.
Publicado: (2014)

Two cases of treatment with aromatase inhibitors and development of miliary osteoma cutis—Is there an association?
por: Schadler, Eric D., et al.
Publicado: (2018)

Multifocal Keloids Associated with Mycobacterium fortuitum following Intralesional Steroid Therapy
por: Kumar, Shailesh, et al.
Publicado: (2011)

A Case of Keloid
por: Vannala, Venkataramana, et al.
Publicado: (2021)

Dupilumab as an adjuvant treatment for keloid-associated symptoms
por: Wong, Audrey Jia Shin, et al.
Publicado: (2021)

Central Precocious Puberty as a Complication of Therapy with Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome
por: Agrawal, Sungeeta, et al.
Publicado: (2019)

Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer
por: Huang, Weiwei, et al.
Publicado: (2020)

Keloid: A case report and review of pathophysiology and differences between keloid and hypertrophic scars
por: Hunasgi, Santosh, et al.
Publicado: (2013)

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
por: Morel, Adeline, et al.
Publicado: (2019)

Delayed granulomatous eruption of the nose associated with ruxolitinib
por: Brown, Margaret, et al.
Publicado: (2020)

Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015)

Systemic sclerosis with keloidal nodules
por: Stadler, Bárbara, et al.
Publicado: (2013)

A Case of Keloids Complicated by Castleman’s Disease: Interleukin-6 as a Keloid Risk Factor
por: Quong, Whitney L., et al.
Publicado: (2017)

Generalized Lichenoid Drug Eruption Associated with Imatinib Mesylate Therapy
por: Ghosh, Sudip Kumar
Publicado: (2013)

Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor
por: Mendley, Susan R., et al.
Publicado: (2015)

A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer
por: Iyengar, Abhinav, et al.
Publicado: (2013)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report
por: Altal, Omar F., et al.
Publicado: (2021)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Keloidal Scleroderma: Case Report and Review
por: Kassira, Sama, et al.
Publicado: (2015)

Rare experience of keloidal dermatofibroma of forehead
por: Kim, Ji Min, et al.
Publicado: (2018)

Challenges in the Management of Upper Lid Keloid
por: Goel, Ruchi, et al.
Publicado: (2022)

Effects of dupilumab on keloid stabilization and prevention
por: Wittmer, Ashley, et al.
Publicado: (2023)

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer
por: Yeruva, Sri Lakshmi Hyndavi, et al.
Publicado: (2015)

Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib
por: Chugh, Shikha, et al.
Publicado: (2013)

Third-generation Aromatase Inhibitor Improved Adult Height in a Japanese Boy with Testotoxicosis
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2014)

Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event
por: Mitsimponas, Nikolaos, et al.
Publicado: (2018)

Review of the Literature on Ocular Complications Associated With Aromatase Inhibitor Use
por: Almafreji, Ibrahim, et al.
Publicado: (2021)

Sorafenib-Associated Facial Acneiform Eruption
por: Cohen, Philip R.
Publicado: (2014)

Eruptive melanocytic nevi associated with ponatinib
por: Devred, Inès, et al.
Publicado: (2018)

Transient eruptive keratoacanthomas associated with nivolumab
por: Antonov, Nina K., et al.
Publicado: (2019)

Eruptive xanthomas
por: Zaremba, Joanna, et al.
Publicado: (2013)

Prophylactic oophorectomy and aromatase inhibitors for premenopausal deep angiomyxoma: A case report and literature review
por: Tonai, Nobutomo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17n6tbtjei51d2rrekkp1uio2m